Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open, Non-comparative, Post-market Clinical Follow-up Investigation to Confirm the Safety and Performance of Avance Solo and Avance Solo Adapt NPWT Systems in Low to Moderate Exuding Chronic Wounds

NCT04753294 is registered in ClinicalTrials.gov with Molnlycke Health Care AB as lead sponsor.

NCT NCT04753294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04753294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open, Non-comparative, Post-market Clinical Follow-up Investigation to Confirm the Safety and Performance of Avance Solo and Avance Solo Adapt NPWT Systems in Low to Moderate Exuding Chronic Wounds
Lead sponsor
Molnlycke Health Care AB
Phase
Not applicable
Overall status
Completed
Start date
June 14, 2021
Completion date
July 21, 2023
Enrollment
136 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

chronic ulcer, diabetic foot ulcer, pressure ulcer, venous leg ulcer